Tower Research Capital (TRC)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.1K | Buy |
3,153
+1,888
| +149% | +$25.2K | ﹤0.01% | 3118 |
|
|
2025
Q1 | $12.9K | Sell |
1,265
-21,719
| -94% | -$221K | ﹤0.01% | 3416 |
|
|
2024
Q4 | $364K | Buy |
22,984
+21,145
| +1,150% | +$335K | 0.01% | 1274 |
|
|
2024
Q3 | $107K | Sell |
1,839
-3,084
| -63% | -$179K | ﹤0.01% | 2177 |
|
|
2024
Q2 | $225K | Buy |
4,923
+4,028
| +450% | +$184K | ﹤0.01% | 1971 |
|
|
2024
Q1 | $59.2K | Sell |
895
-7,367
| -89% | -$488K | ﹤0.01% | 2161 |
|
|
2023
Q4 | $328K | Buy |
8,262
+7,625
| +1,197% | +$303K | ﹤0.01% | 1708 |
|
|
2023
Q3 | $20.3K | Sell |
637
-1,329
| -68% | -$42.4K | ﹤0.01% | 3357 |
|
|
2023
Q2 | $79K | Buy |
1,966
+826
| +72% | +$33.2K | ﹤0.01% | 2207 |
|
|
2023
Q1 | $48K | Buy |
1,140
+654
| +135% | +$27.5K | ﹤0.01% | 2530 |
|
|
2022
Q4 | $23K | Sell |
486
-2,357
| -83% | -$112K | ﹤0.01% | 2997 |
|
|
2022
Q3 | $107K | Sell |
2,843
-789
| -22% | -$29.7K | ﹤0.01% | 2508 |
|
|
2022
Q2 | $100K | Buy |
3,632
+3,255
| +863% | +$89.6K | ﹤0.01% | 2296 |
|
|
2022
Q1 | $21K | Sell |
377
-1,300
| -78% | -$72.4K | ﹤0.01% | 3488 |
|
|
2021
Q4 | $98K | Buy |
1,677
+1,193
| +246% | +$69.7K | ﹤0.01% | 2231 |
|
|
2021
Q3 | $19K | Sell |
484
-526
| -52% | -$20.6K | ﹤0.01% | 3759 |
|
|
2021
Q2 | $43K | Buy |
1,010
+448
| +80% | +$19.1K | ﹤0.01% | 3146 |
|
|
2021
Q1 | $35K | Buy |
562
+370
| +193% | +$23K | ﹤0.01% | 3423 |
|
|
2020
Q4 | $14K | Sell |
192
-6,207
| -97% | -$453K | ﹤0.01% | 4099 |
|
|
2020
Q3 | $247K | Buy |
6,399
+6,052
| +1,744% | +$234K | ﹤0.01% | 2371 |
|
|
2020
Q2 | $13K | Buy |
+347
| New | +$13K | ﹤0.01% | 3901 |
|